As of the latest Form 4 filed Jul 8, 2026.
What Natera Inc insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
Buys plotted up, sells down; bar height is the disclosed dollar value (shares × reported price). Our Form 4 history is only complete from mid-2026, so early months are sparse — the series fills in as more filings land. Open-market purchases and sales only.
Newest filing first — the 150 most recent filings for NTRA.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-07-08 | 2026-07-06 | Rabinowitz Matthew EXECUTIVE CHAIRMAN | SSale | −1.00K | $280.00 | $280K | Yes (planned) | Form 4 ↗ |
| 2026-06-30 | 2026-06-26 | Rubin Eric H Director | AAward | +75.00 | — | — | No | Form 4 ↗ |
| 2026-06-30 | 2026-06-26 | Chapman Rowan E Director | AAward | +103.00 | — | — | No | Form 4 ↗ |
| 2026-06-30 | 2026-06-26 | Chapman Rowan E, Director | AAward | +1.57K | — | — | No | Form 4 ↗ |
| 2026-06-30 | 2026-06-26 | Bertagnolli Monica Director | AAward | +75.00 | — | — | No | Form 4 ↗ |
| 2026-06-30 | 2026-06-26 | Bertagnolli Monica, Director | AAward | +1.57K | — | — | No | Form 4 ↗ |
| 2026-06-30 | 2026-06-26 | Marcus Gail Boxer Director | AAward | +98.00 | — | — | No | Form 4 ↗ |
| 2026-06-30 | 2026-06-26 | Marcus Gail Boxer, Director | AAward | +1.57K | — | — | No | Form 4 ↗ |
| 2026-06-30 | 2026-06-26 | Baynes Roy D. Director | AAward | +75.00 | — | — | No | Form 4 ↗ |
| 2026-06-30 | 2026-06-26 | Baynes Roy D., Director | AAward | +1.57K | — | — | No | Form 4 ↗ |
| 2026-06-30 | 2026-06-26 | Lynch Thomas J. Jr. Director | AAward | +1.91K | — | — | No | Form 4 ↗ |
| 2026-06-30 | 2026-06-26 | ROSENMAN HERM Director | AAward | +106.00 | — | — | No | Form 4 ↗ |
| 2026-06-30 | 2026-06-26 | ROSENMAN HERM, Director | AAward | +1.57K | — | — | No | Form 4 ↗ |
| 2026-06-30 | 2026-06-26 | BOTHA ROELOF Director | AAward | +120.00 | — | — | No | Form 4 ↗ |
| 2026-06-30 | 2026-06-26 | BOTHA ROELOF, Director | AAward | +1.57K | — | — | No | Form 4 ↗ |
| 2026-06-26 | 2026-06-24 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | SSale | −11.1K | $253.39 | $2.82M | Yes (planned) | Form 4 ↗ |
| 2026-06-26 | 2026-06-24 | RABINOWITZ DANIEL, SEC. AND CHIEF LEGAL OFFICER | SSale | −5.07K | $252.31 | $1.28M | Yes (planned) | Form 4 ↗ |
| 2026-06-26 | 2026-06-24 | RABINOWITZ DANIEL, SEC. AND CHIEF LEGAL OFFICER | SSale | −1.20K | $251.60 | $302K | Yes (planned) | Form 4 ↗ |
| 2026-06-26 | 2026-06-24 | RABINOWITZ DANIEL, SEC. AND CHIEF LEGAL OFFICER | SSale | −16.2K | $250.25 | $4.06M | Yes (planned) | Form 4 ↗ |
| 2026-06-26 | 2026-06-24 | ROSENMAN HERM Director | SSale | −16.5K | $250.00 | $4.13M | Yes (planned) | Form 4 ↗ |
| 2026-06-22 | 2026-06-17 | Sheena Jonathan Director | SSale | −15.00 | $222.14 | $3.33K | Yes (planned) | Form 4 ↗ |
| 2026-06-22 | 2026-06-17 | Sheena Jonathan, Director | SSale | −301.00 | $221.39 | $66.6K | Yes (planned) | Form 4 ↗ |
| 2026-06-22 | 2026-06-17 | Sheena Jonathan, Director | SSale | −71.00 | $220.46 | $15.7K | Yes (planned) | Form 4 ↗ |
| 2026-06-22 | 2026-06-17 | Sheena Jonathan, Director | SSale | −96.00 | $219.13 | $21.0K | Yes (planned) | Form 4 ↗ |
| 2026-06-22 | 2026-06-17 | Sheena Jonathan, Director | SSale | −267.00 | $218.18 | $58.3K | Yes (planned) | Form 4 ↗ |
| 2026-06-22 | 2026-06-17 | Sheena Jonathan, Director | SSale | −244.00 | $221.46 | $54.0K | Yes (planned) | Form 4 ↗ |
| 2026-06-22 | 2026-06-17 | Sheena Jonathan, Director | SSale | −122.00 | $220.93 | $27.0K | Yes (planned) | Form 4 ↗ |
| 2026-06-22 | 2026-06-17 | Sheena Jonathan, Director | SSale | −128.00 | $219.26 | $28.1K | Yes (planned) | Form 4 ↗ |
| 2026-06-22 | 2026-06-17 | Sheena Jonathan, Director | SSale | −256.00 | $218.14 | $55.8K | Yes (planned) | Form 4 ↗ |
| 2026-06-17 | 2026-06-16 | Chapman Rowan E Director | SSale | −2.96K | $216.78 | $643K | Yes (planned) | Form 4 ↗ |
| 2026-06-17 | 2026-06-15 | Sheena Jonathan Director | SSale | −300.00 | $213.54 | $64.1K | Yes (planned) | Form 4 ↗ |
| 2026-06-17 | 2026-06-15 | Sheena Jonathan, Director | SSale | −500.00 | $212.42 | $106K | Yes (planned) | Form 4 ↗ |
| 2026-06-17 | 2026-06-15 | Sheena Jonathan, Director | SSale | −600.00 | $211.34 | $127K | Yes (planned) | Form 4 ↗ |
| 2026-06-17 | 2026-06-15 | Sheena Jonathan, Director | SSale | −1.75K | $210.29 | $368K | Yes (planned) | Form 4 ↗ |
| 2026-06-16 | 2026-06-15 | Rabinowitz Matthew EXECUTIVE CHAIRMAN | SSale | −400.00 | $218.72 | $87.5K | Yes (planned) | Form 4 ↗ |
| 2026-06-16 | 2026-06-15 | Rabinowitz Matthew, EXECUTIVE CHAIRMAN | SSale | −3.81K | $217.60 | $829K | Yes (planned) | Form 4 ↗ |
| 2026-06-16 | 2026-06-15 | Rabinowitz Matthew, EXECUTIVE CHAIRMAN | SSale | −6.74K | $216.81 | $1.46M | Yes (planned) | Form 4 ↗ |
| 2026-06-16 | 2026-06-15 | Rabinowitz Matthew, EXECUTIVE CHAIRMAN | SSale | −11.9K | $215.91 | $2.56M | Yes (planned) | Form 4 ↗ |
| 2026-06-16 | 2026-06-15 | Rabinowitz Matthew, EXECUTIVE CHAIRMAN | SSale | −10.3K | $214.72 | $2.22M | Yes (planned) | Form 4 ↗ |
| 2026-06-16 | 2026-06-15 | Rabinowitz Matthew, EXECUTIVE CHAIRMAN | SSale | −7.84K | $213.88 | $1.68M | Yes (planned) | Form 4 ↗ |
| 2026-06-16 | 2026-06-15 | Rabinowitz Matthew, EXECUTIVE CHAIRMAN | SSale | −5.10K | $212.84 | $1.08M | Yes (planned) | Form 4 ↗ |
| 2026-06-16 | 2026-06-15 | Rabinowitz Matthew, EXECUTIVE CHAIRMAN | SSale | −1.24K | $211.81 | $262K | Yes (planned) | Form 4 ↗ |
| 2026-06-16 | 2026-06-15 | Rabinowitz Matthew, EXECUTIVE CHAIRMAN | SSale | −1.83K | $210.73 | $386K | Yes (planned) | Form 4 ↗ |
| 2026-06-16 | 2026-06-15 | Rabinowitz Matthew, EXECUTIVE CHAIRMAN | SSale | −831.00 | $209.83 | $174K | Yes (planned) | Form 4 ↗ |
| 2026-06-16 | 2026-06-12 | Rabinowitz Matthew, EXECUTIVE CHAIRMAN | SSale | −1.60K | $219.36 | $352K | Yes (planned) | Form 4 ↗ |
| 2026-06-16 | 2026-06-12 | Rabinowitz Matthew, EXECUTIVE CHAIRMAN | SSale | −2.13K | $218.17 | $465K | Yes (planned) | Form 4 ↗ |
| 2026-06-16 | 2026-06-12 | Rabinowitz Matthew, EXECUTIVE CHAIRMAN | SSale | −4.28K | $217.32 | $929K | Yes (planned) | Form 4 ↗ |
| 2026-06-16 | 2026-06-12 | Rabinowitz Matthew, EXECUTIVE CHAIRMAN | SSale | −7.18K | $216.51 | $1.55M | Yes (planned) | Form 4 ↗ |
| 2026-06-16 | 2026-06-12 | Rabinowitz Matthew, EXECUTIVE CHAIRMAN | SSale | −3.16K | $215.38 | $681K | Yes (planned) | Form 4 ↗ |
| 2026-06-16 | 2026-06-12 | Rabinowitz Matthew, EXECUTIVE CHAIRMAN | SSale | −5.71K | $214.35 | $1.22M | Yes (planned) | Form 4 ↗ |
| 2026-06-16 | 2026-06-12 | Rabinowitz Matthew, EXECUTIVE CHAIRMAN | SSale | −5.03K | $213.43 | $1.07M | Yes (planned) | Form 4 ↗ |
| 2026-06-16 | 2026-06-12 | Rabinowitz Matthew, EXECUTIVE CHAIRMAN | SSale | −12.1K | $212.27 | $2.58M | Yes (planned) | Form 4 ↗ |
| 2026-06-16 | 2026-06-12 | Rabinowitz Matthew, EXECUTIVE CHAIRMAN | SSale | −2.96K | $211.61 | $626K | Yes (planned) | Form 4 ↗ |
| 2026-06-16 | 2026-06-12 | Rabinowitz Matthew, EXECUTIVE CHAIRMAN | SSale | −3.27K | $210.30 | $687K | Yes (planned) | Form 4 ↗ |
| 2026-06-16 | 2026-06-12 | Rabinowitz Matthew, EXECUTIVE CHAIRMAN | SSale | −2.54K | $209.50 | $531K | Yes (planned) | Form 4 ↗ |
| 2026-06-09 | 2026-06-05 | Marcus Gail Boxer Director | SSale | −116.00 | $218.82 | $25.4K | No | Form 4 ↗ |
| 2026-06-09 | 2026-06-05 | Marcus Gail Boxer, Director | SSale | −3.17K | $218.11 | $692K | No | Form 4 ↗ |
| 2026-06-09 | 2026-06-05 | Marcus Gail Boxer, Director | SSale | −4.69K | $217.30 | $1.02M | No | Form 4 ↗ |
| 2026-06-09 | 2026-06-05 | Marcus Gail Boxer, Director | SSale | −3.02K | $216.06 | $652K | No | Form 4 ↗ |
| 2026-06-09 | 2026-06-05 | Marcus Gail Boxer, Director | MExercise | +11.0K | $22.83 | $251K | No | Form 4 ↗ |
| 2026-06-05 | 2026-06-04 | Chapman Steven Leonard CEO AND PRESIDENT | SSale | −3.41K | $226.97 | $774K | Yes (planned) | Form 4 ↗ |
| 2026-06-05 | 2026-06-04 | Chapman Steven Leonard, CEO AND PRESIDENT | SSale | −6.75K | $226.15 | $1.53M | Yes (planned) | Form 4 ↗ |
| 2026-06-05 | 2026-06-04 | Chapman Steven Leonard, CEO AND PRESIDENT | SSale | −1.63K | $224.99 | $367K | Yes (planned) | Form 4 ↗ |
| 2026-06-05 | 2026-06-04 | Chapman Steven Leonard, CEO AND PRESIDENT | SSale | −1.44K | $223.91 | $323K | Yes (planned) | Form 4 ↗ |
| 2026-06-05 | 2026-06-04 | Chapman Steven Leonard, CEO AND PRESIDENT | SSale | −6.50K | $223.34 | $1.45M | Yes (planned) | Form 4 ↗ |
| 2026-06-05 | 2026-06-04 | Chapman Steven Leonard, CEO AND PRESIDENT | SSale | −2.01K | $222.25 | $446K | Yes (planned) | Form 4 ↗ |
| 2026-06-05 | 2026-06-04 | Chapman Steven Leonard, CEO AND PRESIDENT | SSale | −2.40K | $220.19 | $528K | Yes (planned) | Form 4 ↗ |
| 2026-06-05 | 2026-06-04 | Chapman Steven Leonard, CEO AND PRESIDENT | SSale | −2.76K | $219.08 | $604K | Yes (planned) | Form 4 ↗ |
| 2026-06-05 | 2026-06-04 | Chapman Steven Leonard, CEO AND PRESIDENT | SSale | −1.74K | $218.28 | $380K | Yes (planned) | Form 4 ↗ |
| 2026-06-05 | 2026-06-04 | Chapman Steven Leonard, CEO AND PRESIDENT | SSale | −2.35K | $217.04 | $510K | Yes (planned) | Form 4 ↗ |
| 2026-06-05 | 2026-06-04 | Chapman Steven Leonard, CEO AND PRESIDENT | SSale | −5.50K | $216.13 | $1.19M | Yes (planned) | Form 4 ↗ |
| 2026-06-05 | 2026-06-04 | Chapman Steven Leonard, CEO AND PRESIDENT | SSale | −1.30K | $214.83 | $279K | Yes (planned) | Form 4 ↗ |
| 2026-06-05 | 2026-06-04 | Chapman Steven Leonard, CEO AND PRESIDENT | SSale | −2.50K | $213.44 | $534K | Yes (planned) | Form 4 ↗ |
| 2026-06-05 | 2026-06-04 | Chapman Steven Leonard, CEO AND PRESIDENT | SSale | −832.00 | $212.42 | $177K | Yes (planned) | Form 4 ↗ |
| 2026-06-03 | 2026-06-01 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | SSale | −572.00 | $220.67 | $126K | Yes (planned) | Form 4 ↗ |
| 2026-06-03 | 2026-06-01 | Moshkevich Solomon, PRESIDENT, CLINICALDIAGNOSTICS | SSale | −213.00 | $219.34 | $46.7K | Yes (planned) | Form 4 ↗ |
| 2026-06-03 | 2026-06-01 | Moshkevich Solomon, PRESIDENT, CLINICALDIAGNOSTICS | SSale | −413.00 | $218.84 | $90.4K | Yes (planned) | Form 4 ↗ |
| 2026-06-03 | 2026-06-01 | Moshkevich Solomon, PRESIDENT, CLINICALDIAGNOSTICS | SSale | −1.80K | $217.52 | $392K | Yes (planned) | Form 4 ↗ |
| 2026-06-03 | 2026-06-01 | BOTHA ROELOF Director | SSale | −2.45K | $223.83 | $548K | No | Form 4 ↗ |
| 2026-06-03 | 2026-06-01 | BOTHA ROELOF, Director | SSale | −2.85K | $222.79 | $635K | No | Form 4 ↗ |
| 2026-06-03 | 2026-06-01 | BOTHA ROELOF, Director | SSale | −14.9K | $221.58 | $3.30M | No | Form 4 ↗ |
| 2026-06-03 | 2026-06-01 | BOTHA ROELOF, Director | SSale | −21.3K | $220.94 | $4.71M | No | Form 4 ↗ |
| 2026-06-03 | 2026-06-01 | BOTHA ROELOF, Director | SSale | −10.1K | $219.78 | $2.22M | No | Form 4 ↗ |
| 2026-06-03 | 2026-06-01 | BOTHA ROELOF, Director | SSale | −26.4K | $218.69 | $5.78M | No | Form 4 ↗ |
| 2026-06-03 | 2026-05-29 | Rubin Eric H Director | AAward | +2.12K | — | — | No | Form 4 ↗ |
| 2026-05-28 | 2026-05-26 | Fesko John PRESIDENT, CHIEF BUS. OFFICER | SSale | −1.44K | $202.84 | $292K | Yes (planned) | Form 4 ↗ |
| 2026-05-28 | 2026-05-26 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | SSale | −1.65K | $202.84 | $335K | Yes (planned) | Form 4 ↗ |
| 2026-05-15 | 2026-05-13 | Sheena Jonathan Director | SSale | −9.00 | $203.30 | $1.83K | Yes (planned) | Form 4 ↗ |
| 2026-05-15 | 2026-05-13 | Sheena Jonathan, Director | SSale | −285.00 | $202.68 | $57.8K | Yes (planned) | Form 4 ↗ |
| 2026-05-15 | 2026-05-13 | Sheena Jonathan, Director | SSale | −360.00 | $201.19 | $72.4K | Yes (planned) | Form 4 ↗ |
| 2026-05-15 | 2026-05-13 | Sheena Jonathan, Director | SSale | −96.00 | $199.43 | $19.1K | Yes (planned) | Form 4 ↗ |
| 2026-05-15 | 2026-05-13 | Sheena Jonathan, Director | SSale | −30.00 | $202.84 | $6.09K | Yes (planned) | Form 4 ↗ |
| 2026-05-15 | 2026-05-13 | Sheena Jonathan, Director | SSale | −290.00 | $202.58 | $58.7K | Yes (planned) | Form 4 ↗ |
| 2026-05-15 | 2026-05-13 | Sheena Jonathan, Director | SSale | −345.00 | $201.11 | $69.4K | Yes (planned) | Form 4 ↗ |
| 2026-05-15 | 2026-05-13 | Sheena Jonathan, Director | SSale | −85.00 | $199.52 | $17.0K | Yes (planned) | Form 4 ↗ |
| 2026-05-15 | 2026-05-08 | Sheena Jonathan, Director | SSale | −1.15K | $210.35 | $242K | Yes (planned) | Form 4 ↗ |
| 2026-05-15 | 2026-05-08 | Sheena Jonathan, Director | SSale | −200.00 | $209.57 | $41.9K | Yes (planned) | Form 4 ↗ |
| 2026-05-15 | 2026-05-08 | Sheena Jonathan, Director | SSale | −700.00 | $208.13 | $146K | Yes (planned) | Form 4 ↗ |
| 2026-05-15 | 2026-05-08 | Sheena Jonathan, Director | SSale | −900.00 | $207.24 | $187K | Yes (planned) | Form 4 ↗ |
| 2026-05-15 | 2026-05-08 | Sheena Jonathan, Director | SSale | −200.00 | $205.43 | $41.1K | Yes (planned) | Form 4 ↗ |
| 2026-05-06 | 2026-05-05 | Rabinowitz Matthew EXECUTIVE CHAIRMAN | SSale | −948.00 | $205.22 | $195K | Yes (planned) | Form 4 ↗ |
| 2026-05-06 | 2026-05-05 | Rabinowitz Matthew, EXECUTIVE CHAIRMAN | AAward | +2.39K | — | — | Yes (planned) | Form 4 ↗ |
| 2026-05-06 | 2026-05-05 | Rabinowitz Matthew, EXECUTIVE CHAIRMAN | SSale | −1.70K | $206.77 | $351K | Yes (planned) | Form 4 ↗ |
| 2026-05-06 | 2026-05-05 | Rabinowitz Matthew, EXECUTIVE CHAIRMAN | SSale | −1.45K | $241.39 | $351K | Yes (planned) | Form 4 ↗ |
| 2026-05-06 | 2026-05-05 | Rabinowitz Matthew, EXECUTIVE CHAIRMAN | SSale | −2.89K | $206.77 | $597K | Yes (planned) | Form 4 ↗ |
| 2026-05-06 | 2026-05-04 | Rabinowitz Matthew, EXECUTIVE CHAIRMAN | SSale | −722.00 | $206.16 | $149K | Yes (planned) | Form 4 ↗ |
| 2026-04-29 | 2026-04-29 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | SSale | −200.00 | $197.26 | $39.5K | Yes (planned) | Form 4 ↗ |
| 2026-04-29 | 2026-04-29 | Brophy Michael Burkes, CHIEF FINANCIAL OFFICER | SSale | −1.07K | $194.82 | $208K | Yes (planned) | Form 4 ↗ |
| 2026-04-29 | 2026-04-29 | Brophy Michael Burkes, CHIEF FINANCIAL OFFICER | SSale | −1.00K | $193.78 | $194K | Yes (planned) | Form 4 ↗ |
| 2026-04-29 | 2026-04-29 | Brophy Michael Burkes, CHIEF FINANCIAL OFFICER | SSale | −500.00 | $192.13 | $96.1K | Yes (planned) | Form 4 ↗ |
| 2026-04-29 | 2026-04-29 | Brophy Michael Burkes, CHIEF FINANCIAL OFFICER | SSale | −300.00 | $190.12 | $57.0K | Yes (planned) | Form 4 ↗ |
| 2026-04-29 | 2026-04-29 | Sheena Jonathan Director | SSale | −805.00 | $196.99 | $159K | Yes (planned) | Form 4 ↗ |
| 2026-04-29 | 2026-04-29 | Sheena Jonathan, Director | SSale | −2.27K | $196.22 | $445K | Yes (planned) | Form 4 ↗ |
| 2026-04-29 | 2026-04-27 | Fesko John PRESIDENT, CHIEF BUS. OFFICER | SSale | −917.00 | $204.39 | $187K | Yes (planned) | Form 4 ↗ |
| 2026-04-29 | 2026-04-27 | Fesko John, PRESIDENT, CHIEF BUS. OFFICER | SSale | −771.00 | $203.75 | $157K | Yes (planned) | Form 4 ↗ |
| 2026-04-29 | 2026-04-27 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | SSale | −1.19K | $204.39 | $242K | Yes (planned) | Form 4 ↗ |
| 2026-04-29 | 2026-04-27 | Moshkevich Solomon, PRESIDENT, CLINICALDIAGNOSTICS | SSale | −997.00 | $203.75 | $203K | Yes (planned) | Form 4 ↗ |
| 2026-04-29 | 2026-04-27 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | SSale | −988.00 | $204.39 | $202K | Yes (planned) | Form 4 ↗ |
| 2026-04-29 | 2026-04-27 | RABINOWITZ DANIEL, SEC. AND CHIEF LEGAL OFFICER | SSale | −873.00 | $203.75 | $178K | Yes (planned) | Form 4 ↗ |
| 2026-04-29 | 2026-04-27 | Chapman Steven Leonard CEO AND PRESIDENT | SSale | −3.57K | $204.39 | $729K | Yes (planned) | Form 4 ↗ |
| 2026-04-29 | 2026-04-27 | Chapman Steven Leonard, CEO AND PRESIDENT | SSale | −2.27K | $203.75 | $463K | Yes (planned) | Form 4 ↗ |
| 2026-04-29 | 2026-04-27 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | SSale | −1.22K | $204.39 | $250K | Yes (planned) | Form 4 ↗ |
| 2026-04-29 | 2026-04-27 | Brophy Michael Burkes, CHIEF FINANCIAL OFFICER | SSale | −771.00 | $203.75 | $157K | Yes (planned) | Form 4 ↗ |
| 2026-04-29 | 2026-04-27 | Sheena Jonathan Director | SSale | −188.00 | $204.39 | $38.4K | Yes (planned) | Form 4 ↗ |
| 2026-04-29 | 2026-04-27 | Sheena Jonathan, Director | SSale | −285.00 | $203.75 | $58.1K | Yes (planned) | Form 4 ↗ |
| 2026-04-28 | 2026-04-24 | Rubin Eric H Director | AAward | +5.00 | — | — | No | Form 4 ↗ |
| 2026-04-28 | 2026-04-24 | Chapman Rowan E Director | AAward | +222.00 | — | — | No | Form 4 ↗ |
| 2026-04-28 | 2026-04-24 | Chapman Rowan E, Director | AAward | +114.00 | — | — | No | Form 4 ↗ |
| 2026-04-28 | 2026-04-24 | Bertagnolli Monica Director | AAward | +83.00 | — | — | No | Form 4 ↗ |
| 2026-04-28 | 2026-04-24 | Marcus Gail Boxer Director | AAward | +222.00 | — | — | No | Form 4 ↗ |
| 2026-04-28 | 2026-04-24 | Marcus Gail Boxer, Director | AAward | +108.00 | — | — | No | Form 4 ↗ |
| 2026-04-28 | 2026-04-24 | Baynes Roy D. Director | AAward | +83.00 | — | — | No | Form 4 ↗ |
| 2026-04-28 | 2026-04-24 | Williams Brinkley Ruth Director | AAward | +86.00 | — | — | No | Form 4 ↗ |
| 2026-04-28 | 2026-04-24 | ROSENMAN HERM Director | AAward | +222.00 | — | — | No | Form 4 ↗ |
| 2026-04-28 | 2026-04-24 | ROSENMAN HERM, Director | AAward | +117.00 | — | — | No | Form 4 ↗ |
| 2026-04-28 | 2026-04-24 | BOTHA ROELOF Director | AAward | +222.00 | — | — | No | Form 4 ↗ |
| 2026-04-28 | 2026-04-24 | BOTHA ROELOF, Director | AAward | +132.00 | — | — | No | Form 4 ↗ |
| 2026-04-21 | 2026-04-17 | Sheena Jonathan Director | SSale | −750.00 | $199.59 | $150K | Yes (planned) | Form 4 ↗ |
| 2026-04-21 | 2026-04-17 | Sheena Jonathan, Director | SSale | −750.00 | $199.66 | $150K | Yes (planned) | Form 4 ↗ |
| 2026-04-08 | 2026-04-06 | Rabinowitz Matthew EXECUTIVE CHAIRMAN | FTax | −27.6K | $204.87 | $5.66M | No | Form 4 ↗ |
| 2026-04-08 | 2026-04-06 | Rabinowitz Matthew, EXECUTIVE CHAIRMAN | MExercise | +58.3K | $9.59 | $559K | No | Form 4 ↗ |
| 2026-04-01 | 2026-03-31 | Rabinowitz Matthew EXECUTIVE CHAIRMAN | MExercise | +41.7K | $9.59 | $400K | No | Form 4 ↗ |
| 2026-03-20 | 2026-03-20 | Sheena Jonathan Director | SSale | −280.00 | $200.90 | $56.3K | Yes (planned) | Form 4 ↗ |
| 2026-03-20 | 2026-03-20 | Sheena Jonathan, Director | SSale | −235.00 | $199.88 | $47.0K | Yes (planned) | Form 4 ↗ |
| 2026-03-20 | 2026-03-20 | Sheena Jonathan, Director | SSale | −235.00 | $198.49 | $46.6K | Yes (planned) | Form 4 ↗ |
| 2026-03-20 | 2026-03-20 | Sheena Jonathan, Director | SSale | −371.00 | $200.97 | $74.6K | Yes (planned) | Form 4 ↗ |
| 2026-03-20 | 2026-03-20 | Sheena Jonathan, Director | SSale | −140.00 | $199.82 | $28.0K | Yes (planned) | Form 4 ↗ |
| 2026-03-20 | 2026-03-20 | Sheena Jonathan, Director | SSale | −239.00 | $198.85 | $47.5K | Yes (planned) | Form 4 ↗ |
| 2026-03-20 | 2026-03-18 | Sheena Jonathan, Director | SSale | −1.81K | $198.65 | $360K | Yes (planned) | Form 4 ↗ |
| 2026-03-20 | 2026-03-18 | Sheena Jonathan, Director | SSale | −956.00 | $197.84 | $189K | Yes (planned) | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also NTRA’s full analysis or the market-wide insider trading feed. The tabs above jump to NTRA’s other SEC data.
Source: SEC Form 4 filings for NTRA, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.